MolNFT v1 · #484012 · protein
AlphaFold monomer V2.0 prediction for tryparedoxin (O77404)
O77404: “AlphaFold monomer V2.0 prediction for tryparedoxin (O77404)”. MolNFT v1 #484012 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- Accession
- O77404
- Type
- protein
- Length
- 144 residues
- Chains
- 1
- Collection
- MolNFT v1 / AlphaFold
- Contract
- 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
- Owner
- 0x651207d00689D88967A8252c7789431a4434F46a
- Molecule
- Tryparedoxin
- UniProt
- O77404
Structure
1 distinct chain · 35% helix, 22% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Tryparedoxin | protein | 144 | 35% helix, 22% strand | O77404 |
Modifications
Observed in the structure: 1 disulfide (disulfide).
Compared structures
- 1O73 · Tryparedoxin from trypanosoma brucei · an experimental structure of the same protein · chain A against A, TM-score 0.98
- 1O73 · Tryparedoxin from Trypanosoma brucei · an experimental structure of the same protein · chain A against A, TM-score 0.98
- 6GXG · Tryparedoxin from Trypanosoma brucei in complex with CFT · an experimental structure of the same protein · chain A against B, TM-score 0.97
- 6GXG · Tryparedoxin from trypanosoma brucei in complex with cft · an experimental structure of the same protein · chain A against B, TM-score 0.97
- 6GXY · Tryparedoxin from Trypanosoma brucei in complex with CFT · an experimental structure of the same protein · chain A against A, TM-score 0.97
- 6GXY · Tryparedoxin from trypanosoma brucei in complex with cft · an experimental structure of the same protein · chain A against A, TM-score 0.97
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O77404
- Elsewhere: UniProt O77404 · AlphaFold DB O77404
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.